The document discusses a study on the impact of the COVID-19 pandemic on cancer patients and their ability to receive treatment. Key findings include:
1) Over half of cancer patients had appointments cancelled or postponed, leading to delays in treatment and increased mental stress and anxiety.
2) Clinical trial participation was also impacted, with many trials being put on hold.
3) While doctors provided virtual consultations, concerns about receiving in-person care remain high, especially among recently diagnosed patients and those with late-stage cancer.
4) Fears for the future and anxiety levels rose during the pandemic and remain elevated as some restrictions are lifted.
Community Acquired Pneumonia and other types of pneumonia
for medical students
Detailed information on pneumonia including the following
Definition
Classification
Aetiology
Pathogenesis
Pathological states
Investigations
Treatment & follow up
Complications
Medication
Hospital acquired pneumonia and it’s treatment and management and prevention
Other types of pneumonia
And pneumonia in immune compromised patients
“Cancer Anorexia Cachexia (originally Cancer Cachexia) is a multifactorial syndrome defined by:
Ongoing loss of skeletal muscle mass (with or without loss of fat mass)
Cannot be fully reversed by conventional nutritional support
Leads to progressive functional impairment”.
In this presentation, I discuss a new standard of treatment in cancers which is immunotherapy. I also discuss the few cancers for which it has been approved.
Management of Anemia in cancer patientsAjeet Gandhi
Anemia in cancer patients are important both in terms of quality of life as well as response to therapy. Cause of anemia is multi-factorial and its management is critical in optimizing best outcomes of cancer patients
Don't miss our upcoming webinars. Subscribe today!
Presented by: Marjut Huotari - Vice President, Healthcare Insights at Leger
In this webinar:
The Canadian Cancer Survivor Network commissioned Leger, a Canadian-owned polling and market research firm, to discover how the disruption of cancer care has affected Canadian cancer patients, survivors, and caregivers. This third survey Leger conducted for CCSN took place from June 10 to July 4, 2021.
Join CCSN and Leger as we present the results of the survey on COVID-19 and Cancer Care Disruption in Canada - Wave 3, and hear from members of the cancer community about how the pandemic has directly impacted them.
Watch the YouTube video: https://www.youtube.com/watch?v=CTomgU3AUSQ
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars! Subscribe today!
In this webinar:
In May-June, 2020, the Canadian Cancer Survivor Network (CCSN) commissioned Leger to conduct a national survey to evaluate the impact that COVID-19 has had on cancer patients, survivors, pre-diagnosis patients, and caregivers. The results of our first survey revealed that the pandemic response has triggered another public health crisis - the postponement and cancellation of essential cancer tests, procedures, and treatments.
CCSN commissioned Leger for a second survey in December, 2020 to evaluate the impact that the suspension of cancer services during the first wave is currently having on those who have been affected by cancer.
Join CCSN and Leger as we present the results of the COVID-19 and Cancer Care Disruption in Canada Survey - Wave 2 and hear from members of the cancer community about how the pandemic has directly impacted them.
View the YouTube video: https://youtu.be/qN4Hq7OtBys
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Community Acquired Pneumonia and other types of pneumonia
for medical students
Detailed information on pneumonia including the following
Definition
Classification
Aetiology
Pathogenesis
Pathological states
Investigations
Treatment & follow up
Complications
Medication
Hospital acquired pneumonia and it’s treatment and management and prevention
Other types of pneumonia
And pneumonia in immune compromised patients
“Cancer Anorexia Cachexia (originally Cancer Cachexia) is a multifactorial syndrome defined by:
Ongoing loss of skeletal muscle mass (with or without loss of fat mass)
Cannot be fully reversed by conventional nutritional support
Leads to progressive functional impairment”.
In this presentation, I discuss a new standard of treatment in cancers which is immunotherapy. I also discuss the few cancers for which it has been approved.
Management of Anemia in cancer patientsAjeet Gandhi
Anemia in cancer patients are important both in terms of quality of life as well as response to therapy. Cause of anemia is multi-factorial and its management is critical in optimizing best outcomes of cancer patients
Don't miss our upcoming webinars. Subscribe today!
Presented by: Marjut Huotari - Vice President, Healthcare Insights at Leger
In this webinar:
The Canadian Cancer Survivor Network commissioned Leger, a Canadian-owned polling and market research firm, to discover how the disruption of cancer care has affected Canadian cancer patients, survivors, and caregivers. This third survey Leger conducted for CCSN took place from June 10 to July 4, 2021.
Join CCSN and Leger as we present the results of the survey on COVID-19 and Cancer Care Disruption in Canada - Wave 3, and hear from members of the cancer community about how the pandemic has directly impacted them.
Watch the YouTube video: https://www.youtube.com/watch?v=CTomgU3AUSQ
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don't miss our upcoming webinars! Subscribe today!
In this webinar:
In May-June, 2020, the Canadian Cancer Survivor Network (CCSN) commissioned Leger to conduct a national survey to evaluate the impact that COVID-19 has had on cancer patients, survivors, pre-diagnosis patients, and caregivers. The results of our first survey revealed that the pandemic response has triggered another public health crisis - the postponement and cancellation of essential cancer tests, procedures, and treatments.
CCSN commissioned Leger for a second survey in December, 2020 to evaluate the impact that the suspension of cancer services during the first wave is currently having on those who have been affected by cancer.
Join CCSN and Leger as we present the results of the COVID-19 and Cancer Care Disruption in Canada Survey - Wave 2 and hear from members of the cancer community about how the pandemic has directly impacted them.
View the YouTube video: https://youtu.be/qN4Hq7OtBys
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don’t miss our upcoming webinars. Subscribe today!
About this webinar:
In this webinar, presented by Marjut Huotari, Vice President of Healthcare Insights at Leger, you will learn about cancer patient and caregiver concerns as society opens. How do cancer patients feel? What risks are they willing to take?
About the presenter:
Marjut Huotari has a Bachelor and a Master of Business Administration from the Schulich School of Business, York University. She is a marketing professional with over 20 years of experience working with the pharmaceutical industry, including 14 years working in the pharmaceutical industry on the client side. With Leger, Marjut manages both qualitative and quantitative market research, conducting research with a variety of healthcare practitioners and patients. With her team, she aims to help her clients to understand the issues and help develop solutions.
View the Video: https://bit.ly/youtubeCancerCantWaitCCSNFourthLegersurveyonCOVID19andcancercare
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
How general internists can participate in the continuum of care for patients with cancer. (Talk given at Internal Medicine Grand Rounds, St. Elizabeth Hospital, General Santos City, 10 Feb 2021.)
Don't miss our upcoming webinars! Subscribe today!
In April, CCSN virtually met with MPPs throughout Ontario to discuss our COVID-19 and Cancer Care - Wave 2 Survey. During these meetings, we discussed the difficulty cancer patients and pre-diagnosis patients have had with accessing cancer services during the pandemic and the importance of ensuring the cancer patients receive their 1st and 2nd vaccine doses in a timely manner.
In this webinar, CCSN's Public Policy Analyst Conrad will begin by sharing some of the highlights from our meetings with Ontario MPPs. He will then turn things over to our patient advocates and they will share some of their reflections from our meetings as well as their own experiences with accessing cancer care during the pandemic. Lastly, Conrad will take a closer look at the Ontario data from our survey.
View the YouTube video: https://youtu.be/05u4i89WFfQ
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Don’t miss our upcoming webinars: Subscribe today!
In this webinar:
Our presenter, Filomena Servidio, will be reviewing the results of CCSN’s National Prostate Cancer Survey based on the recently released Prostate Cancer Survey Report. Join us as we learn more about the prostate cancer journey, and the need to better inform and support prostate cancer patients and their caregivers in Canada.
View the video:
https://youtu.be/RHwIsZx6x4A
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
During March, CCSN and patient advocates met with Alberta MLAs to discuss our COVID-19 and Care Care Disruption - Wave 2 Survey and the importance of prioritizing cancer patients in the vaccine rollout. In this webinar, we will hear from Tim Monds, a lung cancer patient advocate, share some outcomes from our meetings, discuss the key findings from our survey, and take a closer look at the Alberta data.
View the YouTube video: https://youtu.be/Tq5OJqA5_Rc
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
About this Webinar: we’ll summarize the findings of a 10-minute online study conducted by Leger among cancer patients who experienced Long-COVID. We identified 119 cancer patients, diagnosed within the past 10 years, who developed symptoms or were diagnosed with Long-COVID. We primarily wanted to understand how Long-COVID impacted cancer patients and their ability to receive treatment. We also asked about the effect on their overall wellbeing, their ability to access Long-COVID treatments and assistance, and the ongoing impact to this day.
About this Presenter: Colette Faust is a Research Director at Leger (largest Canadian-owned market research company) and has 10 years of market research experience, spending the last 3 years in the healthcare industry. As a member of Leger’s North American Healthcare team, Colette has worked on both quantitative and qualitative healthcare research among healthcare professionals, patients, and the general population across a variety of topics including oncology. Colette received her B.A. in Psychology and Media & Communications from Muhlenberg College in Allentown, PA.
Join Fight CRC and Dr. Scott Kopetz to learn about the latest breaking colorectal cancer research from the American Society of Clinical Oncology 2019 Annual Conference.
YCN Breast Educational Meeting 2015-NICE Breast Cancer Quality Standards- E A...Jay Naik
Background to the the NICE Breast Cancer Quality Standards, desinged as simple measures to ensure delivery of quality care. Regional audit data for 3 Trusts presented comparing and contrasting performance against selected audit data.
From surviving to thriving: cancer’s next challengePwC Russia
Рак-диагноз, который никто не хочет услышать. Приуроченный к Всемирному дню борьбы с раком отчет PwC рассказывает об историях тех, кто пережил этот страшный период жизни и не сдался.
Awareness about Liver Cancer in Biotechnology Students_Crimson PublishersCrimsonpublishersCancer
Liver cancer is a major disease caused by sudden mutation occurred in the genes. To cure this disease gemcitabine seems to be affective. Gemcitabine is anticancer agent that has profile containing mild toxicity. It seems to be affective in solid tumors. To check its effectiveness, a questionnaire was developed and the awareness about liver cancer is checked in the post graduate students. All the students were fully aware of this disease.
Slides to accompany presentation by Prof Jourik Gietema, University of Groningen, Netherlands @UnivGroningen, as part of the "Examples of patient-oriented apps" panel.
Survivor Care: an app to enhance survivors’ quality of life
mHealth can help in innovating cancer care pathways: Prof Giatema’s app is a perfect example of how to mix scientific validated medical recommendations with the latest mHealth technology to provide cancer patients with state of the art and cost-effective survivorship care.
----
This was presented at the "Unleashing the mHealth potential for cancer patients" event held on Wednesday 25th May 2016 (16:30-18:30pm) in the European Parliament.
#mHealthCancer
"mHealth and eHealth are becoming realities in Europe: this is demonstrated by the growing size of mHealth apps’ market, by the raising investments in eHealth infrastructures and by the fast adoption, at various degrees, of mHealth applications by patients.
The burden of cancer is also raising: more than 10 million EU citizens are affected by cancer, incidence and prevalence are growing, and the socio-economic impact of cancer heavily burdens both healthcare systems and cancer patients.
The recent political agreement on the text the General Data Protection Regulation and the production of the Privacy Code of Conduct mHealth apps further stir the debate regarding the use of new mHealth technologies within cancer care pathways.
Are cancer patients enjoying the benefits of mHealth?
In which field can cancer patients profit the most from mHealth apps?
Is the regulatory framework supporting the development of useful and safe mHealth apps for cancer patients?
Are there other structural obstacles to the full integration of mHealth apps in the cancer patients’ journey?"
The event will be hosted by MEP Cristian-Silviu Busoi (EPP, Romania), one of ECPC closest champions within the European Parliament and a knowledgeable supporter of the development of eHealth/mHealth in Europe.
The event was followed by a cocktail reception.
Join the discussion on Twitter using #mHealthCancer The event is part of the initiatives for the
2016 European Week Against Cancer #EWAC2016
More information can be found on the European Cancer Patient Coalition's website:
http://www.ecpc.org/pressroom/events/icalrepeat.detail/2016/04/26/61/-/-
About the Webinar: Michelle Colero, Executive Director of Bladder Cancer Canada, will cover the essentials of bladder cancer facts and symptoms while also outlining the support and educational resources provided by Bladder Cancer Canada for those dealing with a diagnosis. Additionally, she’ll share ways individuals can contribute to raising awareness and supporting our community.
About the Webinar: Alcohol is classified as a Group one carcinogen and is estimated to be one of the top three causes of cancer deaths worldwide. Yet, over 40 per cent of people in Canada remain unaware that alcohol consumption increases the risk of developing at least nine cancers. In this presentation, we’ll look at what is and isn’t known about the relationship between alcohol and cancer. We’ll explore what the Canadian Cancer Society is doing to raise awareness of alcohol as a modifiable cancer risk factor, its commitment to funding world-leading research on this subject, and its advocacy for stronger policies that reduce, and increase awareness about the risk of cancer related to, alcohol consumption. Attendees will be invited to seek more information and/or take action on this important topic. We hope you’ll join us in learning more about cancer risk and alcohol — the most commonly used psychoactive substance in Canada.
Dr. Rob Rutledge returns for his first webinar of 2024 to discuss the basics behind emotional intelligence. Learn how to develop greater emotional awareness, and learn how to settle fear and frustration. Dr. Rutledge will also share tips on how to live in a more peaceful and connected way as you navigate through your cancer journey.
About the Webinar: Health technology assessment (HTA), the approval process for drugs and healthcare technology, the processes and organizations that support them, such as Canadian Agency for Drugs and Technologies in Health (CADTH), have evolved over the years in response to changing healthcare system priorities and the need to establish their legitimacy. Don Husereau will provide an overview of current processes in Canada, and highlight their perceived (and real) shortcomings and what can be done to overcome these. He will highlight that some perceived weaknesses (such as review times) are not as bad as they appear while perceived strengths (such as stakeholder involvement) need considerable improvement. He will also discuss other opportunities for HTA to innovate and whether there are current plans to address these.
About this Webinar: The time between regulatory approval for new drugs and when drugs became publicly available to patients averaged 736 days (25 months) in 2022. This is double the average time reported in comparable Organisation for Economic Development (OECD) countries. This webinar will highlight variations in drug listing time for new drugs across time, provinces, and type of drugs (oncology vs. non-oncology). It will also present the specific phases involved in moving a drug from approval stage to listing, and the time spent in each. This Conference Board of Canada analysis uses IQVIA’s Market Access Metrics Database (2012 to 2023), which tracks all new products and their indications through the Canadian access journey.
About the Webinar: Learn about pancreatic cancer symptoms, diagnosis, treatment options, statistics, supports and barriers. The presentation will also include some helpful tools that can improve quality of life for those with pancreatic cancer, including the Craig's Cause's PERT (Pancreatic Enzyme Replacement Therapy) calculator and available patient support programs.
As referenced by John Adams in his 2024 CCSN Webinar on the US importing drugs from Canada, this is a slide deck from Health Canada which outlines the timetable and actions taken by the government on this particular issue.
About this Webinar: John Adams takes a dive behind the headlines, news stories and media releases to better understand any real threats to Canadian patients getting the prescription drugs they need.
About this Webinar: We know that methods of eating and diet are a large part of cancer care, but how can you make your diet work for you in your cancer journey? Dr. Rob Rutelege is back to present the latest science around healthy eating and cancer care. In addition, Dr. Rutledge will share the benefits of time-restricted eating, and how you can incorporate it into your daily routine.
Colorectal cancer is the second leading cause of cancer death in Canada, with approximately 24,100 Canadians diagnosed with the disease in 2023. The incidence of colorectal cancer has been declining in Canadians over 50 years of age, largely due to population-based screening programs. Recent evidence has shown, however, that rates have been increasing in adults younger than 50 years. Given that younger adults are typically classified as at low risk for colorectal cancer, this epidemiologic shift is cause for concern.
Individuals under the age of 50 now represent a significant number of colorectal cancer cases. The disease is often being diagnosed at a later stage, and tumour characteristics tend to be more lethal. As for what is accounting for the increasing trend, ongoing research efforts focus on environmental toxicities, lifestyle patterns, and the gut microbiome.
In this webinar, we will present an overview of the current evidence surrounding the rising rates of colorectal cancer in young adults and discuss the unique needs of this patient population, through screening, diagnosis, treatment, and survivorship. A young colorectal cancer patient will share his lived experience in managing this disease and the impact that cancer has had on himself and his family.
About this Talk: This talk will provide a nutritional perspective on the role of diet in cancer focusing on healthy fats known as omega-3 fatty acids. Sources, amounts and types of omega-3 fatty acids will be highlighted. Clinical and experimental evidence in support of a role for omega-3 fatty acids in the prevention and treatment of breast cancer will be presented. Lastly, some practical strategies to support a healthy diet will be shared.
About the Webinar: Genomic testing has already become commonplace in oncology, but exponential growth in more comprehensive genomic tests, other innovative tests and testing approaches in oncology, as well as a number of other therapeutic areas is expected in the coming years. With the emergence of more complex, more expensive, and more promising tests, policymakers and healthcare providers may be challenged to provide these to patients at the pace of innovation. Don Husereau will describe what conditions are necessary for equitable access to advanced innovative testing, how major Canadian provinces are doing, and what more needs to be done in the coming years to benefit all patients.
About this Webinar: This talk will explore breast screening for women 40-49. The benefits and harms for screening will be discussed, as well as what is unique about breast cancer in women in their 40s. In order to understand the controversy around current guidelines recommending against screening women 40-49, we will review the evidence upon which these guidelines are based, and their impact on breast cancer outcomes for these women.
About this Webinar: This presentation will discuss the pathway to pharmaceutical treatments in Canada that involve health technology assessment reviews and decision making. Observations on the current challenges and the importance of patient input to inform decision making will also be discussed. Finally, the key elements that can be critical to successful outcomes will be presented.
About this Webinar: When Canadians turn on the tap for a drink of water or a shower, we take for granted that the water is safe. Few are aware that old asbestos cement water pipes still deliver water to millions of people. As these pipes age and deteriorate, asbestos erodes into the water and poses health concerns, including cancer.
Dr. Meg Sears, Chair of the Board of Prevent Cancer Now, and board member Julian Branch will talk about the history of asbestos in water, the science behind ingested asbestos, and recent developments.
André Deschamps will show the results of the Europa UOMO Euproms studies. These are the first studies ever from patients for patients, measuring the burden of treatment. More than 5000 patients have shared with us their experiences after treatment. The data has been analyzed by the university of Rotterdam in the Netherlands and has been published in peer reviewed scientific papers.
This webinar will serve as an introduction to Cancer and Work, a website that “was designed to address the unique needs of cancer survivors with returning, remaining, changing work or looking for work after a diagnosis of cancer. The website provides newly created information, resources, and interactive tools for cancer survivors, healthcare providers, employers, and highlights helpful information from across the globe.” The talk will include 10 steps to return to work, and job search ideas for cancer survivors
This webinar will have two perspectives.
Jasveen will be presenting about the impact of cancer and treatment on a person’s physical, cognitive & mental health and how an Occupational therapist can work with the person to gradually overcome these challenges to return to work with or without modifications. The presentation will cover some case studies of past success with the opportunity to answer questions at the end.
Then we will hear from Jen who has experienced her own journey with breast cancer and how she advocated for herself and occupational therapy to help her return to full time employment.
Various cancer treatments can impact one’s gut health and digestive system. This presentation will discuss why a healthy gut is important to overall health. We will talk about the roles the gut is involved in beyond just digestion. We will also discuss nutrition strategies that will support our gut health and promote a healthy microbiome.
In this Webinar, participants will learn about:
– Balancing rising costs and a limited budget
– Eating healthily, food banks, other resources in your community
– Budget formats that work for cancer patients
– Money management
– Debit and credit management
– Credit counselling
– Consumer protection
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Impact of COVID-19 on Cancer Patients and Their Ability to Receive Treatment
1. IMPACT OF COVID-19 CRISIS ON
CANCER PATIENTS AND THEIR
ABILITY TO RECEIVE TREATMENT
Wednesday, July 15, 2020
11:00 am
Presented by Marjut Huotari,
VP – Healthcare Insights, Leger
1
2. Research context and objectives
Research methodology
• Recruitment
• Research methodology
Key findings
Conclusion
Q&A
1
2
3
4
5
OVERVIEW
2
3. RESEARCH CONTEXT AND OBJECTIVES
Leger, on behalf of the Canadian Cancer Survivor Network (CCSN), and with the support of Advocacy Solutions,
conducted a study to assess the extent to which the disruption of cancer care caused by COVID-19 is impacting
cancer patients and caregivers, from an emotional and physical wellness perspective.
• Have appointments been cancelled or rescheduled?
• for treatment, surgery, etc.
• Have there been delays in diagnosis?
• are patients waiting for tests, e.g. biopsies, ultrasounds, etc. to confirm a
diagnosis?
• Have patients avoided going to the ER?
• for symptoms related to their cancer diagnosis etc.
• What is the emotional and mental impact of diagnosis and treatment
delays?
• How are patients and caregivers interacting with the doctor managing their
cancer
• virtual consults, in person visits, etc.
• Has clinical trial participation been affected or put on hold?
Key topics addressed
in the survey
3
4. RESEARCH METHODOLOGY – SAMPLE SIZE
Data collection took place from May 22nd to June
10th , 2020.
Web survey of 1,243 Canadians, including
960 Canadians diagnosed with cancer, 206
Caregivers and 77 Canadians in the pre-
diagnosis stage.
The survey was made available in both
English and French.
REGIONAL ACHIEVEMENTS
4
QUE 33%
ON 35%
AB 10%
BC 11% SK 2%
ATL 6%
MB 2%
5. RESEARCH METHODOLOGY – RECRUITMENT
SCREENING CRITERIA:
• 18 years or older and currently living in Canada
• Respondents qualified as:
A patient, if they were diagnosed with cancer
A caregiver, if a currently living family member / someone they
care for was diagnosed with cancer
Pre-diagnosis, if they are in the process of trying to determine
if they have cancer, or to rule out cancer
• A maximum of 35% of patients to be in remission
RECRUITMENT:
• Most respondents were recruited via our LEO PANEL – Leger’s proprietary consumer panel
with nearly 500,000 members (largest in Canada):
909 patients
205 caregivers
77 pre-diagnosis patients
• A portion of respondents were recruited with the help of CCSN via an open survey link:
51 patients
1 caregiver
5
6. 6
Even split by gender Tend to skew older: 59 YEARS on averageRegionally representative across Canada
QUE 32%
ON 36%
AB 10%
BC 11%
SK 2% ATL 6%
MB 3%
RESPONDENT PROFILE – PATIENTS
BREAST (28%) and PROSTATE (21%) cancer
account for about half.
Other cancers among ~1 in 10 patients include
colon / rectal, melanoma, lung, and bladder.
28% 21%
Stage 1
20%
Stage 2
16%
Stage 3
10%
Stage 4 /
Metastatic
10%
Remission
35%
1 in 10 say they are unsure of their stage of cancer.
<2 YEARS
30%
2-5 YEARS
35%
6-10 YEARS
19%
>10 YEARS
16%
TIME SINCE
DIAGNOSIS
varies greatly
among patients;
a MAJORITY
(two thirds) were
diagnosed in the
PAST 5 YEARS.
48%52%
RURAL: 24%
TOWN/CITY: 51%
URBAN/METRO: 25%
Good mix of locations by population
7. 7
Good mix of all ages: 47 YEARS on averageRegionally representative across Canada
QUE 32%
ON 33%
AB 10%
BC 14%
SK 1% ATL 8%
MB 3%
RESPONDENT PROFILE – CAREGIVERS
<2 YEARS
50%
2-5 YEARS
27%
6-10 YEARS
11%
>10 YEARS
13%
TIME SINCE
DIAGNOSIS
varies but skews
towards more
recently diagnosed;
HALF were
diagnosed within
the last 2 years
40%60%
RURAL: 19%
TOWN/CITY: 56%
URBAN/METRO: 24%
Good mix of locations by population
Most common cancer types of
person being cared for
LUNG
CANCER: 19%
PROSTATE
CANCER: 13%
BREAST
CANCER: 34%
COLON / RECTAL
CANCER: 20%
RELATIONSHIP TO THE CANCER PATIENT
Spouse / partner
– 23%
Daughter (in-law)
– 19%
Mother (in-law) –
10%
Son (in-law) –
10%
Skews towards females
1 in 10 say they are unsure of their stage of cancer.
8. 8
Skews younger with 75% under 55 years
46 YEARS on average
Majority from QC, followed by ON
QUE 48%
ON 32%
AB 12%
BC 4%
SK 1% ATL 1%
MB 1%
RESPONDENT PROFILE – PRE-DIAGNOSIS
66%34%
RURAL: 14%
TOWN/CITY: 51%
URBAN/METRO: 32%
Tend to skew towards city / metroSkews towards males
As they wait for a
possible cancer
diagnosis…
10. KEY STUDY FINDINGS
RESTRICTIONS put in place to manage the COVID-19 crisis have
resulted in considerable DISRUPTION to many aspects of cancer care
in Canada
Despite consulting doctors using virtual modes of interaction, DELAYS
in APPOINTMENTS and TREATMENT have had a MAJOR IMPACT on
patients and their caregivers
The many DISRUPTIONS to cancer care have taken a MENTAL and
EMOTIONAL TOLL
CONCERNS about receiving adequate cancer care BOTH DURING and
AFTER COVID-19 fuel anxieties
1
2
3
4
11. 54% HAVE HAD APPOINTMENTS
CANCELLED, POSTPONED OR RESCHEDULED
16% AVOIDED VISITING AN ER
15% HAVE HAD SURGERIES / PROCEDURES
CANCELLED
PATIENTS
50%
RECENTLY DIAGNOSED – 68%
12%
12%
RECENTLY DIAGNOSED – 22%
RECENTLY DIAGNOSED – 22%
CAREGIVERS
66%
RECENTLY DIAGNOSED – 85%
26%
23%
METASTATIC STAGE – 49%
LIVING IN RURAL
AREAS – 31%
PRE-DIAGNOSIS
74%
40%
30%
NOTE:
RECENTLY DIAGNOSED = DIAGNOSED <2 YEARS AGO
METASTATIC STAGE = STAGE 4 CANCER
11
THREE-QUARTERS of PRE-DIAGNOSIS and RECENTLY DIAGNOSED patients have had their
APPOINTMENTS CANCELLED, POSTPONED or RESCHEDULED
12. 11% EXPERIENCED DELAYS IN STARTING /
CONTINUING TREATMENT
PATIENTS
8%
RECENTLY DIAGNOSED – 17%
CAREGIVERS
23%
RECENTLY DIAGNOSED – 29%
LIVING IN RURAL AREAS – 32%
20% of RECENTLY DIAGNOSED patients experienced DELAYS in RECEIVING TREATMENT.
62% of RECENTLY DIAGNOSED patients in a CLINICAL TRIAL reported it was PUT ON HOLD / STOPPED
12
CLINICAL TRIALS WERE
ALSO IMPACTED
Four-in-ten (43%) patients, who were enrolled in or in process of being enrolled in a clinical trial
report the clinical trial being put on hold or stopped altogether
Six-in-ten (62%) recently diagnosed patients report a clinical trial being put on hold or
stopped altogether
Five-in-ten (52%) of those in adjuvant stage and four-in-ten (39%) of those in
metastatic stage of cancer report having an impact on clinical trial
NOTE:
RECENTLY DIAGNOSED = DIAGNOSED <2 YEARS AGO
METASTATIC STAGE = STAGE 4 CANCER
ADJUVANT STAGE = STAGE 1/2/3 CANCER
13. 74% of those who experienced DELAYS in APPOINTMENTS say it had a MAJOR
IMPACT on their MENTAL and EMOTIONAL health
IN SPITE OF CONSULTING DOCTORS
VIRTUALLY, DELAYS IN
APPOINTMENTS AND
TREATMENT HAVE HAD A HUGE
IMPACT
PATIENTS
68%
CAREGIVERS
89%
PRE-DIAGNOSIS
82%
Worried / concerned
Anxious
Stressed
DELAYS HAVE ESPECIALLY HAD A
MAJOR IMPACT ON MENTAL
AND EMOTIONAL HEALTH WITH
MANY HIGHLIGHTING BEING:
“First I would like be to say NO ONE
should have any cancer appointments
cancelled or rescheduled. This is cancer
– it may even already have spread. Not
having my treatments is a nightmare.
All you keep doing in your head is
asking ‘has it spread, am I going to die
sooner or will I make it to my next
appointment?”
“I was worried as her appointment was
scheduled for the end of March. We
tried to reach the doctor and it was
concerning that their voicemail was
always full. It wasn't until that week
that we found out the appointment
was cancelled.”
“Having the doctors postpone and
cancel my appointments and
treatments makes me a bit worried
because I'm scared that what if it
spreads during the time being without
noticing”
“I am supposed to have testing done at
every appointment. I have been put off
for three (3) times since Covid-19
started. I'm worried that I may still
have growing cells. I was also supposed
to have a CT/MRI as well but have
heard nothing on a date, canceled or
otherwise.”
“It was really stressful because the day
appointments was fixed all plans and
everything was scheduled but when it is
postponed then you have to schedule
again and change everything.”
“I'm a mess!!! Not knowing is driving
me insane. I can't think straight, I don't
sleep, I don't eat....”
13
14. COVID-19 HAS AFFECTED* MOST ASPECTS OF
EVERYONE’S LIFE, CAUSING FEARS FOR THE
FUTURE & INCREASED LEVEL OF ANXIETY
56% EXPRESS FEARS FOR THE FUTURE
PATIENTS
51%
49%
36%
CAREGIVERS
73%
68%
PRE-DIAGNOSIS
74%
77%
68%
FEARS FOR THE FUTURE are MOST PRONOUNCED for those who are RECENTLY
DIAGNOSED (68%) or PRE-DIAGNOSIS (74%) and those in the METASTATIC STAGE (74%)
RECENTLY DIAGNOSED – 65%
METASTATIC STAGE – 67%
RECENTLY DIAGNOSED – 76%
METASTATIC STAGE – 94%
55% HAVE INCREASED LEVELS OF ANXIETY 73%
RECENTLY DIAGNOSED – 63%
METASTATIC STAGE – 65%
43% FEAR THE CANCER WILL PROGRESS
RECENTLY DIAGNOSED – 53%
METASTATIC STAGE – 58%
RECENTLY DIAGNOSED – 82%
METASTATIC STAGE – 94%
RECENTLY DIAGNOSED – 82%
METASTATIC STAGE – 79%
NOTE: RECENTLY DIAGNOSED = DIAGNOSED <2 YEARS AGO
METASTATIC STAGE = STAGE 4 CANCER
14
*SIGNIFICANT + SOME AFFECT
15. PATIENTS CAREGIVERS PRE-DIAGNOSIS
VIRTUAL HEALTHCARE
OFTEN REPLACED
IN-PERSON VISITS MODES OF INTERACTION
DURING THE PANDEMIC
85%
31%
76%
34%
GPs
Specialists
Virtual
(telephone, video consult,
e-mail, instant messaging,
text / SMS)
In-person
SATISFACTION
(VERY/SOMEWHAT
SATISFIED)
88%
92%
89%
95%
81%
35%
80%
31%
GPs
Specialists
SATISFACTION
(VERY/SOMEWHAT
SATISFIED)
75%
78%
81%
100%
72%
39%
72%
40%
GPs
Specialists
SATISFACTION
(VERY/SOMEWHAT
SATISFIED)
80%
78%
92%
70%
Majority had a virtual
consult with their
doctor during the
pandemic, including
telephone, video
consult, e-mail, instant
messaging / online
chat, text / SMS.
Among all virtual
modes of interactions,
telephone consult was
used the most
15
Among those who INTERACTED with a physician DURING THE PANDEMIC, 83%
had a VIRTUAL CONSULTATION
16. Although many consulted doctors virtually, 71% remain CONCERNED about RECEIVING IN-PERSON
CARE – especially those recently diagnosed and pre-diagnosis patients
56% ARE CONCERNED ABOUT THEIR ABILITY TO RECEIVE
HOSPITAL CARE IF NEEDED
56% ARE CONCERNED ABOUT THEIR ABILITY TO BE CARED
FOR IN ER IF NEEDED
54% ARE CONCERNED BEING ABLE TO GET TESTS RELATED
TO CANCER
54% ARE CONCERNED ABOUT BEING ABLE TO SEE
DOCTOR MANAGING CANCER FOR FOLLOW-UPS
54% ARE CONCERNED ABOUT BEING ABLE TO GET HELP
FOR SIDE EFFECTS RELATED TO TREATMENT OR NEW
SYMPTOMS
51% ARE CONCERNED ABOUT BEING ABLE TO RECEIVE
CANCER TREATMENT IN TIMELY FASHION
PATIENTS CAREGIVERS PRE-DIAGNOSIS
51%
51%
49%
49%
48%
46%
MANY PATIENTS AND THEIR CAREGIVERS
EXPRESSED CONCERNS*
RECENTLY DIAGNOSED – 57%
METASTATIC STAGE – 58%
RECENTLY DIAGNOSED – 58%
RECENTLY DIAGNOSED – 59%
RECENTLY DIAGNOSED – 61%
RECENTLY DIAGNOSED – 57%
RECENTLY DIAGNOSED – 54%
75%
72%
70%
73%
76%
67%
RECENTLY DIAGNOSED – 78%
61%
60%
59%
61%
59%
N/A
*VERY + SOMEWHAT CONCERNED
NOTE: RECENTLY DIAGNOSED = DIAGNOSED <2 YEARS AGO & METASTATIC STAGE = STAGE 4 CANCER
16
17. Even as restrictions lift, 50% of those surveyed, especially those in METASTATIC STAGE (73%)
say CONCERNS about receiving ADEQUATE CANCER CARE are FUELING ANXIETIES
ANXIETY LEVELS ROSE CONSIDERABLY DURING
THE HEIGHT OF THE COVID-19 PANDEMIC
Five-in-ten (49%) patients reported being very or
somewhat anxious; the most anxious being:
Those with metastatic cancer (72%)
Those recently diagnosed (64%)
Those diagnosed with lung cancer (65%)
Almost eight-in-ten (76%) caregivers said they were
anxious.
This number increases to nine-in-ten (91%)
among those caring for patients in metastatic
stage
Seven-in-ten (71%) pre-diagnosis patients say they were
anxious during the height of the COVID-19 pandemic
35%
49%
44%
64%
76% 74%
65%
71%
64%
Patients Caregivers Pre-diagnosis
PRIOR to COVID-19
being declared a pandemic and
restrictions put in place
DURING the HEIGHT of
COVID-19
pandemic, when self-isolation
restrictions were in place
CURRENTLY,
as restrictions begin to
relax and ease
AS RESTRICTIONS EASE, LEVELS OF ANXIETY
REMAIN ELEVATED
Four-in-ten (44%) patients report currently being anxious, with higher levels of anxiety among:
Those with metastatic cancer (67%)
Those recently diagnosed (56%)
Among the caregiver group in particular there is very little easing of anxiety.
Three-quarters (74%) of caregivers report currently being anxious, especially those caring for patients with metastatic cancer (91%)
Anxiety remains high among pre-diagnosis patients with two-thirds (64%) reporting currently being anxious
NOTE: RECENTLY DIAGNOSED = DIAGNOSED <2 YEARS AGO & METASTATIC STAGE = STAGE 4 CANCER
17
18. PATIENTS CAREGIVERS PRE-DIAGNOSIS
47%
47%
33%
AS THE COVID-19 RESTRICTIONS BEGIN TO
LIFT, MANY PATIENTS AND THEIR CAREGIVERS
REMAIN CONCERNED*
69%
70%
61%
66%
68%
60%
70%
70% of PRE-DIAGNOSIS patients are CONCERNED about DELAYS IN DIAGNOSING their cancer
N/A N/A
RECENTLY DIAGNOSED – 53%
ADJUVANT STAGE – 54%
RECENTLY DIAGNOSED – 43%
*VERY + SOMEWHAT CONCERNED
NOTE: RECENTLY DIAGNOSED = DIAGNOSED <2 YEARS AGO
ADJUVANT STAGE = STAGE 1/2/3 CANCER
18
52% ARE CONCERNED ABOUT DELAYS IN BEING
ABLE TO SCHEDULE APPOINTMENTS
52% ARE CONCERNED ABOUT DELAYS IN
RECEIVING TREATMENT IN A TIMELY FASHION
39% ARE CONCERNED ABOUT DELAYS
AVAILABILITY OF NEW CANCER TREATMENTS
70% PRE-DIAGNOSIS PATIENTS ARE CONCERNED
ABOUT DELAYS IN GETTING CANCER DIAGNOSTIC
TESTING AND PROCEDURES
20. CONCLUSIONS
Overall, 54% have had their CANCER CARE APPOINTMENTS CANCELLED, POSTPONED OR RESCHEDULED.
• THREE-QUARTERS of PRE-DIAGNOSIS and RECENTLY DIAGNOSED patients report having appointments
cancelled, postponed or rescheduled.
74% say delays in appointments and treatment have had a MAJOR IMPACT on their MENTAL and EMOTIONAL
HEALTH.
• METASTATIC and RECENTLY DIAGNOSED patients report highest levels of anxiety.
The majority of patients (83%) who consulted a doctor during the pandemic did so VIRTUALLY; however 71%
remained CONCERNED about receiving IN-PERSON CARE DURING THE PANDEMIC.
Even as restrictions lift, 50% say CONCERNS about RECEIVING ADEQUATE CANCER CARE are FUELING ANXIETIES.
• 70% of PRE-DIAGNOSIS patients are CONCERNED about DELAYS IN DIAGNOSING their cancer.
1
2
3
4
20
21. CANADIAN CANCER SURVIVOR NETWORK
CONTACT INFO
1750 Courtwood Crescent, Suite 210
Ottawa, ON K2C 2B5
Telephone / Téléphone : 613-898-1871
E-mail: jmanthorne@survivornet.ca or info@survivornet.ca
Website: www.survivornet.ca
Twitter: @survivornetca
Facebook: www.facebook.com/CanadianSurvivorNet
Instagram: @survivornet_ca
Pinterest: http://pinterest.com/survivornetwork/